• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Celldex Therapeutics Inc

+ Add to Watchlist

CLDX:US

14.2400 USD 0.4500 3.06%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Celldex Therapeutics Inc (CLDX)

Open: 14.6200 Day's Range: 14.1100 - 14.9300 Volume: 2,536,066
Previous Close: 14.6900 52wk Range: 11.3400 - 38.8400 1-Yr Rtn: +13.65%

Stock Chart for CLDX

No chart data available.
  • CLDX:US 14.2400
  • 1D
  • 1M
  • 1Y
14.6900
Interactive CLDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLDX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0300
Est. EPS (USD) (12/2014) -1.1120
Est. PEG Ratio -
Market Cap (M USD) 1,272.46
Shares Outstanding (M) 89.36
30 Day Average Volume 2,798,872
Price/Book (mrq) 3.9740
Price/Sale (ttm) 266.8097
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLDX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLDX

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

Anthony Salvatore MarucciPresident/CEOAvery W Catlin "Chip"Senior VP/CFO/Secretary
Thomas DavisSenior VP/Chief Medical OfcrTibor KelerSenior VP/Chief Scientific Ofcr
More Company Profile & Key Executives for CLDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil